Brézillon Christophe, Haustant Michel, Dupke Susann, Corre Jean-Philippe, Lander Angelika, Franz Tatjana, Monot Marc, Couture-Tosi Evelyne, Jouvion Gregory, Leendertz Fabian H, Grunow Roland, Mock Michèle E, Klee Silke R, Goossens Pierre L
Institut Pasteur, Pathogénie des Toxi-Infections Bactériennes, Paris, France.
Robert Koch-Institut, Centre for Biological Threats and Special Pathogens (ZBS 2), Berlin, Germany.
PLoS Negl Trop Dis. 2015 Apr 1;9(4):e0003455. doi: 10.1371/journal.pntd.0003455. eCollection 2015 Apr.
Emerging B. cereus strains that cause anthrax-like disease have been isolated in Cameroon (CA strain) and Côte d'Ivoire (CI strain). These strains are unusual, because their genomic characterisation shows that they belong to the B. cereus species, although they harbour two plasmids, pBCXO1 and pBCXO2, that are highly similar to the pXO1 and pXO2 plasmids of B. anthracis that encode the toxins and the polyglutamate capsule respectively. The virulence factors implicated in the pathogenicity of these B. cereus bv anthracis strains remain to be characterised. We tested their virulence by cutaneous and intranasal delivery in mice and guinea pigs; they were as virulent as wild-type B. anthracis. Unlike as described for pXO2-cured B. anthracis, the CA strain cured of the pBCXO2 plasmid was still highly virulent, showing the existence of other virulence factors. Indeed, these strains concomitantly expressed a hyaluronic acid (HA) capsule and the B. anthracis polyglutamate (PDGA) capsule. The HA capsule was encoded by the hasACB operon on pBCXO1, and its expression was regulated by the global transcription regulator AtxA, which controls anthrax toxins and PDGA capsule in B. anthracis. Thus, the HA and PDGA capsules and toxins were co-regulated by AtxA. We explored the respective effect of the virulence factors on colonisation and dissemination of CA within its host by constructing bioluminescent mutants. Expression of the HA capsule by itself led to local multiplication and, during intranasal infection, to local dissemination to the adjacent brain tissue. Co-expression of either toxins or PDGA capsule with HA capsule enabled systemic dissemination, thus providing a clear evolutionary advantage. Protection against infection by B. cereus bv anthracis required the same vaccination formulation as that used against B. anthracis. Thus, these strains, at the frontier between B. anthracis and B. cereus, provide insight into how the monomorphic B. anthracis may have emerged.
在喀麦隆(CA菌株)和科特迪瓦(CI菌株)分离出了可导致类炭疽病的新型蜡样芽孢杆菌菌株。这些菌株不同寻常,因为其基因组特征显示它们属于蜡样芽孢杆菌物种,尽管它们携带两个质粒,即pBCXO1和pBCXO2,这两个质粒与炭疽芽孢杆菌的pXO1和pXO2质粒高度相似,分别编码毒素和聚谷氨酸荚膜。这些炭疽芽孢杆菌蜡样芽孢杆菌菌株致病性所涉及的毒力因子仍有待鉴定。我们通过经皮和经鼻接种小鼠和豚鼠来测试它们的毒力;它们的毒力与野生型炭疽芽孢杆菌一样强。与报道的pXO2缺失的炭疽芽孢杆菌不同,缺失pBCXO2质粒的CA菌株仍然具有高毒力,表明存在其他毒力因子。事实上,这些菌株同时表达透明质酸(HA)荚膜和炭疽芽孢杆菌聚谷氨酸(PDGA)荚膜。HA荚膜由pBCXO1上的hasACB操纵子编码,其表达受全局转录调节因子AtxA调控,AtxA在炭疽芽孢杆菌中控制炭疽毒素和PDGA荚膜。因此,HA和PDGA荚膜以及毒素由AtxA共同调节。我们通过构建生物发光突变体来探究毒力因子对CA菌株在宿主体内定殖和传播的各自影响。单独表达HA荚膜会导致局部增殖,并且在经鼻感染期间会局部扩散到相邻的脑组织。HA荚膜与毒素或PDGA荚膜共同表达能够实现全身扩散,从而提供明显的进化优势。预防炭疽芽孢杆菌蜡样芽孢杆菌感染所需的疫苗配方与预防炭疽芽孢杆菌所用的相同。因此,这些处于炭疽芽孢杆菌和蜡样芽孢杆菌边界的菌株,为了解单形性炭疽芽孢杆菌可能的出现方式提供了线索。